1. Inicio
  2. Proyectos y Estudios Clínicos
  3. Enhancing Whole Genome Sequencing (WGS) and/or Reverse Transcription Polymerase Chain Reaction (RT-PCR) national infrastructures and capacities to respond to the Covid-19 pandemic in Spain - HERA Incubator

Enhancing Whole Genome Sequencing (WGS) and/or Reverse Transcription Polymerase Chain Reaction (RT-PCR) national infrastructures and capacities to respond to the Covid-19 pandemic in Spain - HERA Incubator

Datos básicos

Código:
EU21/16
Dotación:
108.716,65 €
Año Inicial:
2021
Año final:
2022
PROYECTO Investigación clínica EUROPEA Subvención

Objetivos del proyecto

The general objective of the action is to enhance and/or improve national public health WGS and/or RT-PCR capacity. Specific objetives: 1) To establish WGS capacity in regional public health laboratories with few experience in routine sequencing. 2) To increase the WGS capacity in regional public health laboratories that are sequencing a limited number of samples weekly. 3) Evaluation of reagents and consumables to improve the process of sequencing and increase of the number of clinical samples sequenced with a good quality. 4) To hired staff in 32 laboratories at regional and at national level ISCIII. 5) At National level ISCIII coordination of several tasks for improving the technical capacity of regional laboratories. 6) At national level ISCIII, to develop a national SARS-CoV-2 data hub for centralizing genome sequences analysis.

Unidades de investigación

Documentos

  • No hay documentos

Participantes

Financiadores

COMISIÓN EUROPEA

Compartir